person

V. D.

Country
Belgium
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 42 partner sites.

Specializations

Acute Myeloid Leukemia & Myelodysplastic Syndromes

The investigator concentrates on Acute Myeloid Leukemia and Myelodysplastic Syndrome driven by genetic lesions.

  • Combination of epigenetic modulators with targeted kinase inhibitors
  • Therapeutic strategies for IDH1/2‑mutated disease
  • FLT3‑directed treatment approaches

Research activities are centered at Hôpital Jolimont, Haine‑Saint‑Paul, Belgium.

B‑cell Non‑Hodgkin Lymphoma

Focus is placed on innovative immunotherapy for B‑cell Non‑Hodgkin Lymphoma subtypes.

  • Bispecific antibody regimens combined with antibody‑drug conjugates
  • Evaluation of novel CD20‑targeted agents
  • Optimization of response‑guided dosing schedules

Research activities are centered at Hôpital Jolimont, Haine‑Saint‑Paul, Belgium.

Hormone‑Receptor Positive Breast Cancer

Clinical work emphasizes endocrine‑resistant Hormone‑Receptor Positive Breast Cancer.

  • Integration of AKT pathway inhibitors with CDK4/6 blockade
  • Assessment of next‑generation oral SERDs
  • Strategies to prevent distant metastasis in ctDNA‑positive patients

Research activities are centered at Hôpital Jolimont, Haine‑Saint‑Paul, Belgium.

Advanced Prostate Cancer

Investigation targets high‑risk and metastatic Prostate Cancer in vulnerable populations.

  • Androgen deprivation therapy combined with next‑generation AR antagonists
  • Radiotherapy‑enhanced protocols for localized high‑risk disease
  • Evaluation of metastasis‑free survival endpoints

Research activities are centered at Hôpital Jolimont, Haine‑Saint‑Paul, Belgium.

Non‑Small Cell Lung Cancer & Targeted Therapies

Therapeutic interest includes molecularly defined Non‑Small Cell Lung Cancer.

  • c‑Met overexpression as a driver for antibody‑drug conjugate treatment
  • Combination of checkpoint inhibition with chemotherapy backbones
  • Exploration of EGFR‑wildtype subpopulations

Research activities are centered at Hôpital Jolimont, Haine‑Saint‑Paul, Belgium.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.